Providing AI supported dermatology solutions in partnership with the NHS

DERM AI in use

Reducing costs and adding valuable benefits

DERM, our unique AI technology, supports clinicians in their assessment of skin lesions. These range from malignant and pre-malignant lesions to benign lesions.

The Skin Analytics system also enables local dermatologists to review referred cases remotely, allowing them to direct patients to the best assessment or treatment option


Latest News

Skin Analytics achieves Class IIa UKCA Mark for DERM. The UK’s first and only Class IIa certified AI dermatology device

Now a Class IIa medical device, DERM, uses machine learning algorithms to recognise the most common malignant, pre-malignant and benign skin lesions, including melanoma – the fifth most common cancer in the UK. Using a decade’s worth of research and development on skin lesions, it is designed to accelerate patient diagnosis and relieve pressure on the healthcare system. 

read more

Contact us